These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 16946524

  • 1. Effect of glimepiride and glibenclamide on S-warfarin 7-hydroxylation by human liver microsomes, recombinant human CYP2C9.1 and CYP2C9.3.
    Iwakawa S, Miyashita K, Hashimoto Y, Kuroda T.
    Biol Pharm Bull; 2006 Sep; 29(9):1983-5. PubMed ID: 16946524
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Drug-drug interaction of losartan and glimepiride metabolism by recombinant microsome CYP2C9*1, 2C9*3, 2C9*13, and 2C9*16 in vitro.
    Chen SZ, Pan PP, Shen LB, Xu SS, Dai DP, Geng PW, Cai J, Cai JP, Hu GX.
    Int J Clin Pharmacol Ther; 2014 Sep; 52(9):732-8. PubMed ID: 24986093
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes.
    Niemi M, Cascorbi I, Timm R, Kroemer HK, Neuvonen PJ, Kivistö KT.
    Clin Pharmacol Ther; 2002 Sep; 72(3):326-32. PubMed ID: 12235454
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effects of sesamin on CYP2C9-dependent 7-hydroxylation of S-warfarin.
    Fujii M, Yasuda K, Sakaki T.
    Drug Metab Pharmacokinet; 2020 Aug; 35(4):368-373. PubMed ID: 32601017
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions.
    Rettie AE, Korzekwa KR, Kunze KL, Lawrence RF, Eddy AC, Aoyama T, Gelboin HV, Gonzalez FJ, Trager WF.
    Chem Res Toxicol; 1992 Aug; 5(1):54-9. PubMed ID: 1581537
    [Abstract] [Full Text] [Related]

  • 13. Oxidation of celecoxib by polymorphic cytochrome P450 2C9 and alcohol dehydrogenase.
    Sandberg M, Yasar U, Strömberg P, Höög JO, Eliasson E.
    Br J Clin Pharmacol; 2002 Oct; 54(4):423-9. PubMed ID: 12392591
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison in the in vitro inhibitory effects of major phytocannabinoids and polycyclic aromatic hydrocarbons contained in marijuana smoke on cytochrome P450 2C9 activity.
    Yamaori S, Koeda K, Kushihara M, Hada Y, Yamamoto I, Watanabe K.
    Drug Metab Pharmacokinet; 2012 Oct; 27(3):294-300. PubMed ID: 22166891
    [Abstract] [Full Text] [Related]

  • 16. R(+)XK469 inhibits hydroxylation of S-warfarin by CYP2C9.
    Yong WP, Kim TW, Undevia SD, Innocenti F, Ratain MJ.
    Eur J Cancer; 2009 Jul; 45(11):1904-8. PubMed ID: 19464879
    [Abstract] [Full Text] [Related]

  • 17. Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19.
    Wienkers LC, Wurden CJ, Storch E, Kunze KL, Rettie AE, Trager WF.
    Drug Metab Dispos; 1996 May; 24(5):610-4. PubMed ID: 8723744
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro inhibition of CYP2C9-mediated warfarin 7-hydroxylation by iguratimod: possible mechanism of iguratimod-warfarin interaction.
    Yamaori S, Takami K, Shiozawa A, Sakuyama K, Matsuzawa N, Ohmori S.
    Biol Pharm Bull; 2015 May; 38(3):441-7. PubMed ID: 25757926
    [Abstract] [Full Text] [Related]

  • 20. Effects of acid and lactone forms of statins on S-warfarin 7-hydroxylation catalyzed by human liver microsomes and recombinant CYP2C9 variants (CYP2C9.1 and CYP2C9.3).
    Shiozawa A, Yamaori S, Kamijo S, Ohmori S.
    Drug Metab Pharmacokinet; 2021 Feb; 36():100364. PubMed ID: 33341662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.